Guillain-Barré Syndrome Associated with SARS-CoV-2 Infection: A Case Report

Submitted: 12 November 2020
Accepted: 8 May 2021
Published: 31 August 2021
Abstract Views: 694
PDF: 286
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.


  • Mohammad Darvishi Aerospace and Sub-Aquatic Medical Faculty, Aja University of Medical Sciences, Tehran, Iran, Islamic Republic of.
  • Hamze Shahali Aerospace and Sub-Aquatic Medical Faculty, Aja University of Medical Sciences, Tehran, Iran, Islamic Republic of.
  • Azade Amirabadi Farahani Department of Medical Pathology, Medical Faculty, Tehran University of Medical Sciences, Tehran, Iran, Islamic Republic of.

A 56-year-old man was referred to the emergency department for the subacute onset of and weakness in the lower extremities, paraesthesia and pain. He was diagnosed with SARS-CoV-2 pneumonia and then, he received the necessary treatment according to national protocol. Radiographic, laboratory, and electroneurographic findings indicated an acute polyradiculoneuritis with prominent demyelination and suggesting the diagnosis of Guillain-Barr syndrome associated with COVID-19 infection.

Casadevall A, Pirofski LA. The convalescent sera option for containing COVID-19. J Clin Invest. 2020 Apr 1;130(4):1545-1548. DOI:

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323(11):1061-1069. Erratum in: JAMA. 2021 Mar 16;325(11):1113. DOI:

Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 2020 Jun;92(6):552-555. Epub 2020 Mar 11. DOI:

Alberti P, Beretta S, Piatti M, Karantzoulis A, Piatti ML, Santoro P, Viganò M, Giovannelli G, Pirro F, Montisano DA, Appollonio I, Ferrarese C. Guillain-Barré syndrome related to COVID-19 infection. Neurol Neuroimmunol Neuroinflamm. 2020 Apr 29;7(4):e741. DOI:

Karimi N, Sedaghat Z. Letter to the editor. Concerning the article entitled ''Guillain Barre syndrome associated with COVID-19 infection: A case report". J Clin Neurosci. 2020 Sep;79:257-258. Epub 2020 Jul 4. DOI:

Jacobs BC, Rothbarth PH, van der Meché FG, Herbrink P, Schmitz PI, de Klerk MA, van Doorn PA. The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study. Neurology. 1998 Oct;51(4):1110-5. DOI:

Mcgrath TM. Infections of the Central Nervous System, 4th edn. Chap 20. Guillain-Barré Syndrome. Accessed via https://doctorlib. info/ infectiology/infections-central-nervous-system/21.html.

Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ, Keenlyside RA, Ziegler DW, Retailliau HF, Eddins DL, Bryan JA. Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977. Am J Epidemiol. 1979 Aug;110(2):105-23. DOI:

Brison E, Jacomy H, Desforges M, Talbot PJ. Glutamate excitotoxicity is involved in the induction of paralysis in mice after infection by a human coronavirus with a single point mutation in its spike protein. J Virol. 2011 Dec;85(23):12464-73. Epub 2011 Sep 28. DOI:

Zhao K, Huang J, Dai D, Feng Y, Liu L, Nie S. Acute myelitis after SARS-CoV-2 infection: a case report. medRxiv preprint. Mar 2020. DOI:

Ashrafi MR, Azizimalamiri R, Shervin Badv R, Tavasoli AR, Nikkhah A, Montazerlotfelahi H, et al. Coronavirus, Its Neurologic Manifestations, and Complications. Iran J Pediatr. 2020 April; 30(2):e102569. DOI:

Darvishi, M., Shahali, H., & Farahani, A. A. (2021). Guillain-Barré Syndrome Associated with SARS-CoV-2 Infection: A Case Report. European Journal of Translational Myology, 31(3).


Download data is not yet available.